NasdaqCM - Delayed Quote USD
aTyr Pharma, Inc. (ATYR)
5.20
-0.23
(-4.24%)
At close: June 13 at 4:00:01 PM EDT
5.21
+0.01
+(0.19%)
After hours: June 13 at 7:56:21 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 20,562 | 4 |
| Sales | 2,153 | 2 |
| Net Shares Purchased (Sold) | 18,409 | 6 |
| Total Insider Shares Held | 1.99M | -- |
| % Net Shares Purchased (Sold) | 0.90% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| GROSS JANE A Director | Purchase at price 4.00 per share. | Direct | 15,000 | Mar 17, 2025 |
| BROADFOOT JILL MARIE Chief Financial Officer | Sale at price 3.78 per share. | Direct | 4,740 | Feb 4, 2025 |
| DENYES NANCY General Counsel | Sale at price 3.78 per share. | Direct | 3,398 | Feb 4, 2025 |
| BROADFOOT JILL MARIE Chief Financial Officer | -- | Direct | -- | Feb 3, 2025 |
| SHUKLA SANJAY S Chief Executive Officer | -- | Direct | -- | Feb 3, 2025 |
| DENYES NANCY General Counsel | -- | Direct | -- | Feb 3, 2025 |
| SCHIMMEL PAUL R Director | Purchase at price 1.74 - 1.93 per share. | Indirect | 184,613 | Jul 24, 2024 |
| DENYES NANCY General Counsel | Purchase at price 1.86 per share. | Direct | 9,276 | Jun 5, 2024 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 1.81 per share. | Direct | 36,140 | May 31, 2024 |
| COUGHLIN TIMOTHY P Director | Purchase at price 1.75 per share. | Indirect | 87,500 | May 30, 2024 |
| BROADFOOT JILL MARIE Chief Financial Officer | Sale at price 1.69 per share. | Direct | 2,687 | Feb 6, 2024 |
| BROADFOOT JILL MARIE Chief Financial Officer | -- | Direct | -- | Feb 5, 2024 |
| SHUKLA SANJAY S Chief Executive Officer | -- | Direct | -- | Feb 5, 2024 |
| DENYES NANCY General Counsel | -- | Direct | -- | Feb 5, 2024 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 1.17 - 1.18 per share. | Direct | 17,646 | Dec 12, 2023 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 1.11 - 1.14 per share. | Direct | 16,703 | Nov 13, 2023 |
| SHUKLA SANJAY S Chief Executive Officer | Purchase at price 2.01 per share. | Direct | 30,224 | Jul 28, 2023 |
Related Tickers
MNKD MannKind Corporation
3.7100
-3.13%
LRMR Larimar Therapeutics, Inc.
2.8800
-1.03%
UNCY Unicycive Therapeutics, Inc.
0.6814
+6.82%
SGMT Sagimet Biosciences Inc.
8.27
-3.95%
URGN UroGen Pharma Ltd.
12.03
+8.57%
IOVA Iovance Biotherapeutics, Inc.
2.2400
-3.03%
CAPR Capricor Therapeutics, Inc.
11.78
-15.49%
NUVB Nuvation Bio Inc.
1.7300
-4.42%
MREO Mereo BioPharma Group plc
2.7600
-0.72%
NKTR Nektar Therapeutics
8.59
-1.94%